Skip to content

Released Nov 14, 2022, after the close

10-Q filed Nov 14, 2022, 45 days after period end · 0001789769-22-000098

Q3 2022 · 10-Q
Revenue—
Net Income-$56.22MN/M vs Q3 2021N/M vs Q2 2022
EPS Diluted-$0.43N/M vs Q3 2021N/M vs Q2 2022
Operating Income-$56,649,000N/M
Operating Cash Flowderived-$40,877,000N/M
Free Cash Flowderived-$66,076,000N/M

What the release said

The release

Same quarter

MetricQ3 2022Q3 2021Q3 2020
Revenue—$0.00$52.00K
Net Income-$56.22M-$43.01M-$7.26M
EPS Diluted-$0.43-$0.33-$0.43

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Instil Bio, Inc. · CIK 1789769 · Engraved from SEC EDGAR